Concepedia

D. Cibula

DC

Statistics

Publications

3

Citations

48

H-Index

3

Active since

2022

Affiliations

General University Hospital in Prague(Current)

Charles University

Centre Léon Bérard

Centre François Baclesse

Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe

D. Cibula is an author at General University Hospital in Prague specializing in cancer pharmacology, oncology, and ovarian cancer.

Publications per year

2022–2025

3

Publications

3

747MO First results from the ENGOT-GYN2/GOG-3051/BOUQUET phase II biomarker-directed platform study: Cobimetinib (cobi) or atezolizumab (atezo) + bevacizumab (bev) for persistent/recurrent rare epithelial ovarian cancer (eOC)

Isabelle Laure Ray-Coquard, Sandro Pignata, June‐Yong Lee et al. · Annals of Oncology · 2023 · 17 citations · Full text

, , +14

Dostarlimab and niraparib in primary advanced ovarian cancer

Anne‐Claire Hardy‐Bessard, E. Pujade-Lauraine, Richard G. Moore et al. · Annals of Oncology · 2025 · 16 citations · Full text

, , +10

LBA30 Phase III ATALANTE/ov29 trial: Atezolizumab (Atz) versus placebo with platinum-based chemotherapy (Cx) plus bevacizumab (bev) in patients (pts) with platinum-sensitive relapse (PSR) of epithelial ovarian cancer (OC)

J.E. Kurtz, E. Pujade-Lauraine, A. Oaknin et al. · Annals of Oncology · 2022 · 15 citations

, , +17

1–3 of 3